Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

NCT04835129 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Isatuximab (for run-in portion)
DRUG: Isatuximab (for expansion)
DRUG: Pomalidomide
DRUG: Elotuzumab
DRUG: Dexamethasone

Sponsor

Medical College of Wisconsin